CANNACTIVA

💣 HOT DEALS PRE-BLACK FRIDAY: UP TO -50%! 🚀

⭐ +15,000 reviews — 4.8/5

🔥 LIMITED OFFERS · FILL YOUR CART! 🛒

🚀 Free shipping in 48-72 h from €60 🔥

🔥 NEW OFFERS EVERY WEEK 🔥

💣 HOT DEALS PRE-BLACK FRIDAY: UP TO -50%! 🚀

CBD FlowerCBD HashCBD oilCBD physiotherapyCBD skincareAccessoriesCBD bundlesArtClothingCannabis booksBlog
Cannactiva CBD footer

CBD and hemp derivatives made with love

CBD HIGHLIGHTS

  • CBD flower
  • CBD hash
  • Indoor CBD flower
  • Zkittlez CBD
  • Gorilla Glue CBD
  • CBD oil
  • CBD oil 5%
  • CBD oil 10%
  • CBD cream
  • CBD packs
  • CBD wholesale

NEWSLETTER

Want to hear about our offers and get exclusive discounts and gifts? Subscribe here:

SHOPS

Madrid shopC/ Argumosa, 27
28012, Madrid, Spain
Barcelona shopPlaça d'Osca, 6
08014, Barcelona, Spain

CONTACT

  • Contact us
  • (+34) 932 20 48 98
  • info@cannactiva.com
  • Instagram

MEMBERS OF

Cannabishub
Cannabmed
European Industrial Hemp Association
Cluscann

REVIEWS

  • Trustpilot
  • Google – Barcelona shop
  • Google – Madrid shop
  • Cannactiva reviews

CBD products are not medicines and are intended for external use only. Consult a specialist before use if you experience symptoms of pain or illness. Information from Cannactiva and its products is not intended to diagnose, treat or prevent any disease.

Sale restricted to adults aged 18 and over. Products obtained from EU-certified industrial hemp seeds. THC content below 0.3%.

Cannactiva © 2026 All rights reserved

  • Privacy and cookie policy
  • Legal notice
  • Shipping policy: discreet and fast
  • Returns policy
  • Refund policy
  • Terms and conditions
  • Certificates (COA)
  • About us

Cannactiva © 2026 All rights reserved

  1. Home/
  2. CBD blog/
  3. CBD and wellness/
  4. Cannabis and CBD in multiple sclerosis: current research
CBD and wellness

Cannabis and CBD in multiple sclerosis: current research

Cannabiscientia•May 24, 2024

Last updated: October 30, 2026

CBDPain & discomfortCannabis research
Cannabis and CBD in multiple sclerosis: current research

To mark World Multiple Sclerosis Day on 30 May, we have put together this informative article on the use of cannabis-based therapies for symptoms such as spasticity and pain. Please remember that this is an informative article on current scientific research in this field, and that its content is not intended to diagnose, prevent or treat any disease. Speak to your doctor if you have any questions about it.

Multiple sclerosis is a debilitating autoimmune disease that affects the central nervous system. In the search for treatments for this chronic condition, cannabis is one of the current areas of research. Today on the Cannactiva blog we look at the current information on the potential use of cannabis-based therapies for multiple sclerosis. This article is an extract from Cannabiscientia's Handbook of Principles of Clinical Cannabinology.

What is multiple sclerosis?

Multiple sclerosis (MS) is a chronic autoimmune neuroinflammatory disorder that affects the central nervous system, specifically the brain and spinal cord. At the root of this disorder is an autoimmune reaction in which the immune system mistakenly attacks the myelin sheath of the neurons. As a result, lesions (demyelinated plaques) appear, which interfere with the way the nerves send signals, leading to the various symptoms of MS. (1)

Symptoms

The various signs and symptoms of multiple sclerosis depend on where the lesions are located in the brain and spinal cord. Common signs and symptoms include: (1)

  • Spasticity
  • Weakness
  • Sensory disturbances
  • Painful spasms
  • Ataxia
  • Tremors
  • Optic neuritis and complex ophthalmoplegia
  • Fatigue and dysphagia

Given the varied course and symptoms of MS, treatment strategies are tailored to the individual needs of each patient, with a focus on improving quality of life. (2)

Spasticity, an unusual stiffness or tightness of the muscles, stands out as one of the most common and challenging symptoms, which highlights the need for effective management options.

Conventional treatment of multiple sclerosis

Treatment for MS is divided into disease-modifying therapies and symptomatic therapies (3):

  • Disease-modifying therapies: these aim to reduce the frequency and severity of relapses, helping to maintain periods of remission and to slow the progression of the disease, often with medicines such as interferon beta and Copaxone; despite their benefits, these treatments can have severe side effects that limit their use.
  • Symptomatic therapies are designed to relieve the disabling symptoms of MS, but they can also come with side effects that restrict their use. (3)

The potential of cannabis as a therapeutic option in multiple sclerosis

Research into cannabis for managing the symptoms of multiple sclerosis began in earnest in the 1970s, driven by anecdotal reports and the scientific research that followed. (4)

Early studies suggested that cannabis could offer significant relief from spasticity, which prompted further research into its therapeutic potential.

Key clinical studies on cannabis and spasticity

Research has shown that cannabis relieves spasticity and pain in patients with multiple sclerosis. Overall, the scientific evidence demonstrates the effectiveness of cannabis and cannabinoids, albeit with some limitations in objective efficacy and in certain symptom areas.

A 1999 study in Germany of 128 people using cannabis for therapeutic purposes found that 71% of the MS patients who used cannabis (herbal cannabis, hash, tinctures and, in only 5 cases, dronabinol or Marinol) reported improvements in spasticity without serious side effects. (5)

In 2003, a major study highlighted the potential benefits of cannabis extracts on MS symptoms, including spasticity and pain, although it noted limited efficacy on objective measures (6). The results of that study were later confirmed by another study from the same research group, using a more objective measurement. (7)

Subsequent research by Professor Wade and colleagues, and by Collin and colleagues, in the UK, reaffirmed the efficacy of Sativex®, a cannabis spray. The results showed significant improvements and good tolerability among patients (8-10). Thanks to these and similar studies, Sativex® has been approved in Spain and in other European countries for the treatment of spasticity in multiple sclerosis.

Recently, researchers have sought to address the drawbacks of conventional cannabinoid therapies through nanotechnology-based therapeutic systems. For MS, this innovation aims to improve the stability of cannabinoids, reduce the doses required and cross the blood–brain barrier, targeting MS lesions with less toxicity and fewer side effects on healthy nerve tissue (11). Various types of nano-cannabinoids have been developed, including lipid nanoparticles, micelles, silica nanoparticles and carbon nanotubes.

Medical cannabis extract

CBD in autoimmune diseases

Effective cannabis strains, cannabinoids and dosage for multiple sclerosis

When considering the type of cannabis and cannabinoids for MS, both tetrahydrocannabinol (THC) and cannabidiol (CBD) have shown potential benefits, although their effectiveness varies depending on the associated symptoms being treated.

Sativex® is an oromucosal spray medicine with a balanced THC:CBD content (2.7 mg / 2.5 mg THC/CBD) that has been particularly effective in managing spasticity.

Doses of cannabis-based treatments such as Sativex® usually start low and are adjusted according to the patient's response and tolerance, to minimise side effects while maximising the therapeutic benefits.

However, the optimal dosage and the choice between THC, CBD or a combination of both should always be tailored to the individual and always supervised by a health professional experienced in cannabinoid therapy.

Conclusions from clinical studies

In 2014, the American Academy of Neurology carried out a review of cannabis-based treatments for neurological conditions such as MS (12).

This review examined 34 clinical studies and concluded that both cannabis extract preparations and pure THC (whether synthetic or natural) are effective in relieving spasticity in MS. However, their efficacy on objective measures was limited. On the effectiveness of inhaled cannabis, the scientific evidence is insufficient.

For the bladder disorders associated with MS, Sativex® (nabiximols) was the only cannabinoid preparation found to be effective. For MS-induced tremors, all the cannabinoid preparations were ineffective.

Side effects and considerations

Cannabis-based medicines generally show a favourable tolerability profile, with side effects classed as mild to moderate. (12 - 14)

These include:

  • Dizziness
  • Dry mouth
  • Disorientation
  • Impaired concentration and coordination
  • To a lesser extent, psychiatric symptoms such as psychosis or depression.

Nevertheless, it is advisable to start treatment with low doses, adjusted gradually, to minimise these effects. The potential worsening of psychiatric symptoms or cognitive decline from cannabis treatment calls for a thorough assessment of the patient before therapy begins.

Drops of CBD oil

CBD side effects

Conclusion

As treatments for multiple sclerosis evolve, cannabis- and cannabinoid-based therapies are emerging as potential therapeutic options. It is important to note that, as a medical treatment, the appropriateness of medical cannabis therapies must be prescribed and supervised by a specialist professional.

In addition, the effective use of cannabis-based therapies involves personalised strategies and ongoing communication between patients and doctors.

More information on medical cannabis

Health professionals looking to deepen their understanding of the clinical use of cannabinoids and to get practical, evidence-based guidance can turn to Cannabiscientia's Handbook of Principles of Clinical Cannabinology, from which this article has been extracted.

Note: This is an informative article and is not intended to prevent, diagnose or treat any disease. Its content may complement, but should never replace, any diagnosis or treatment of any disease or symptom. Cannactiva products are not medicines and are intended for external use. The authors and Cannactiva accept no responsibility for any misuse of this information. Please bear in mind that new scientific evidence may have emerged since the date of publication. For all these reasons, speak to your doctor before using CBD or if you have any questions about it.

References
  1. Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018 Dec;31(6):752-759.
  2. Gold R, Hartung HP. Towards individualised multiple-sclerosis therapy. Lancet Neurol. 2005 Nov;4(11):693-4.
  3. Baldassari LE, Fox RJ. Therapeutic Advances and Challenges in the Treatment of Progressive Multiple Sclerosis. Drugs. 2018 Oct;78(15):1549-1566.
  4. Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology. 2004;62(11):2098–100.
  5. Schnelle M, Grotenhermen F, Reif M, Gorter RW. Results of a standardised survey on the medical use of cannabis products in the German-speaking area. Forsch Komplementarmed. 1999 Oct;6 Suppl 3:28-36.
  6. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A, UK MS Research Group: Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial. Lancet 2003, 362:1517-1526.
  7. Zajicek JP, Sanders HP, Wright DE, et al. Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up. J Neurol Neurosurg Psychiatry.
  8. Wade D., Makela P., House H., Bateman C., Robson P. (2006) Long-term use of a cannabis-based medicine in the treatment of spasticity and other symptoms in multiple sclerosis. Mult Scler 12: 639-645.
  9. Collin C., Davies P., Mutiboko I., Ratcliffe S. (2007) Randomised controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J Neurol 14: 290-296.
  10. Wade D., Collin C., Stott C., Duncombe P. (2010) Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis. Mult Scler 16: 707-714.
  11. Roua A Nouh, Ahmed Kamal, Oluwaseyi Oyewole, et al. Unveiling the Potential of Cannabinoids in Multiple Sclerosis and the Dawn of Nano-Cannabinoid Medicine. Pharmaceutics. 2024 Feb 7;16(2):241.
  12. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurological disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Apr 29;82(17):1556-63.
  13. Papathanasopoulos P., Messinis L., Lyros E., Kastellakis A., Panagis G. (2008) Multiple sclerosis, cannabinoids, and cognition. J Neuropsychiat Clin Neurosci 20: 36-51.
  14. Robson P. (2011) Abuse potential and psychoactive effects of delta-9- tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine. Expert Opin Drug Saf 10: 675-685.

More about CBD and wellness

View all
CBD for skin: benefits and how to use it
25 Jun 2026·By Laura Salas

CBD for skin: benefits and how to use it

The benefits of CBD for the skin, how to apply it (topical use) and which CBD skincare to choose, according to scientific studies.

Read more →
Effects of CBD: what it does in your body and how it works
5 Jun 2026·By Andrea Rezes Esmeraldino

Effects of CBD: what it does in your body and how it works

What effects CBD has on the body: what it feels like, how it acts, whether it gets you high, whether it is addictive and how long it lasts. A clear, science-based guide.

Read more →
CBD for muscle recovery: benefits and how to use it
3 Jun 2026·By Masha Burelo, PhD

CBD for muscle recovery: benefits and how to use it

How CBD supports muscle recovery: pain relief, less inflammation and better rest. Ways to use it (creams and oils) and what the science says.

Read more →
CBD for athletes: benefits, sports performance and what the science says
2 Jun 2026·By Masha Burelo, PhD

CBD for athletes: benefits, sports performance and what the science says

Cannabis has many uses for athletes. From CBD physiotherapy creams to CBD oil and hemp protein, you're sure to find what best suits your needs.

Read more →
CBDPain & discomfortCannabis research